| Year |
Citation |
Score |
| 2021 |
Okoye NC, Phelps TE, Charles A, McCormick JB, Wycoff DE, Lydon JD, Embree MF, Guthrie J, Kelley SP, Barnes CL, Ketring AR, Hennkens HM, Jurisson SS. Recovery, recycling and re-irradiation of enriched Ru metal targets for cost effective production of Rh. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 176: 109847. PMID 34218122 DOI: 10.1016/j.apradiso.2021.109847 |
0.605 |
|
| 2020 |
Makris G, Bandari RP, Kuchuk M, Jurisson SS, Smith CJ, Hennkens HM. Development and Preclinical Evaluation of Tc- and Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors. Molecular Imaging and Biology. PMID 32886303 DOI: 10.1007/S11307-020-01537-1 |
0.314 |
|
| 2019 |
Baumeister JE, Mitchell AW, Kelley SP, Barnes CL, Jurisson SS. Steric influence of salicylaldehyde-based Schiff base ligands on the formation of trans-[Re(PR)(Schiff base)] complexes. Dalton Transactions (Cambridge, England : 2003). PMID 31393493 DOI: 10.1039/C9Dt02630D |
0.372 |
|
| 2019 |
Makris G, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM. Somatostatin receptor targeting with hydrophilic [Tc/Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes. Nuclear Medicine and Biology. 71: 39-46. PMID 31129499 DOI: 10.1016/J.Nucmedbio.2019.04.004 |
0.337 |
|
| 2019 |
Okoye NC, Baumeister JE, Najafi Khosroshahi F, Hennkens HM, Jurisson SS. Chelators and metal complex stability for radiopharmaceutical applications Radiochimica Acta. 107: 1087-1120. DOI: 10.1515/Ract-2018-3090 |
0.323 |
|
| 2019 |
Makris G, Jurisson S, Smith C, Hennkens H. Organometallic 99mTc/186Re-NOTA and NODAGA complexes utilizing a GRPR-targeting peptide antagonist Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30198-2 |
0.308 |
|
| 2018 |
Radford LL, Papagiannopoulou D, Gallazzi F, Berendzen A, Watkinson L, Carmack T, Lewis MR, Jurisson SS, Hennkens HM. Synthesis and evaluation of Re/Tc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent. Bioorganic & Medicinal Chemistry. PMID 30594453 DOI: 10.1016/J.Bmc.2018.12.028 |
0.407 |
|
| 2018 |
Makris G, Radford LL, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM. NOTA and NODAGA [Tc]Tc- and [Re]Re-tricarbonyl complexes: Radiochemistry and first example of a [Tc]Tc-NODAGA somatostatin receptor-targeting bioconjugate. Bioconjugate Chemistry. PMID 30412382 DOI: 10.1021/Acs.Bioconjchem.8B00670 |
0.375 |
|
| 2018 |
Feng Y, Phipps MD, Phelps TE, Okoye NC, Baumeister JE, Wycoff DE, Dorman EF, Wooten AL, Vlasenko V, Berendzen AF, Wilbur DS, Hoffman TJ, Cutler CS, Ketring AR, Jurisson SS. Evaluation of Se/As generator and production of Se for supplying As as a potential PET imaging radionuclide. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 143: 113-122. PMID 30408634 DOI: 10.1016/J.Apradiso.2018.10.026 |
0.642 |
|
| 2018 |
Baumeister JE, Reinig KM, Barnes CL, Kelley SP, Jurisson SS. Technetium and Rhenium Schiff Base Compounds for Nuclear Medicine: Syntheses of Rhenium Analogues to Tc-Furifosmin. Inorganic Chemistry. PMID 30239194 DOI: 10.1021/Acs.Inorgchem.8B02156 |
0.377 |
|
| 2018 |
Feng Y, DeGraffenreid AJ, Phipps MD, Rold TL, Okoye NC, Gallazzi FA, Barnes CL, Cutler CS, Ketring AR, Hoffman TJ, Jurisson SS. A trithiol bifunctional chelate forAs: A matched pair theranostic complex with high in vivo stability. Nuclear Medicine and Biology. 61: 1-10. PMID 29571038 DOI: 10.1016/J.Nucmedbio.2018.03.001 |
0.647 |
|
| 2017 |
Reinig KM, Seibert R, Velazquez D, Baumeister J, Najafi Khosroshahi F, Wycoff W, Terry J, Adams JE, Deakyne CA, Jurisson SS. Pertechnetate-Induced Addition of Sulfide in Small Olefinic Acids: Formation of [TcO(dimercaptosuccinate)2](5-) and [TcO(mercaptosuccinate)2](3-) Analogues. Inorganic Chemistry. PMID 28994595 DOI: 10.1021/Acs.Inorgchem.7B02001 |
0.317 |
|
| 2017 |
Feng Y, Phelps TE, Carroll V, Gallazzi F, Sieckman G, Hoffman TJ, Barnes CL, Ketring AR, Hennkens HM, Jurisson SS. Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment. Dalton Transactions (Cambridge, England : 2003). PMID 28951905 DOI: 10.1039/C7Dt02407J |
0.724 |
|
| 2017 |
Mastren T, Radchenko V, Bach HT, Balkin ER, Birnbaum ER, Brugh M, Engle JW, Gott MD, Guthrie J, Hennkens HM, John KD, Ketring AR, Kuchuk M, Maassen JR, Naranjo CM, ... ... Jurisson SS, et al. Bulk production and evaluation of high specific activity (186g)Re for cancer therapy using enriched (186)WO3 targets in a proton beam. Nuclear Medicine and Biology. 49: 24-29. PMID 28288384 DOI: 10.1016/J.Nucmedbio.2017.02.006 |
0.628 |
|
| 2017 |
Balkin ER, Gagnon K, Dorman E, Emery R, Li Y, Wooten AL, Smith BE, Strong KT, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Scale-up of high specific activity 186gRe production using graphite-encased thick 186W targets and demonstration of an efficient target recycling process Radiochimica Acta. 105. DOI: 10.1515/Ract-2017-2780 |
0.614 |
|
| 2016 |
Radford L, Gallazzi F, Watkinson L, Carmack T, Berendzen A, Lewis MR, Jurisson SS, Papagiannopoulou D, Hennkens HM. Synthesis and evaluation of a (99m)Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors. Nuclear Medicine and Biology. 47: 4-9. PMID 28043006 DOI: 10.1016/J.Nucmedbio.2016.12.002 |
0.324 |
|
| 2016 |
Demoin DW, Dame AN, Minard WD, Gallazzi F, Seickman GL, Rold TL, Bernskoetter N, Fassbender ME, Hoffman TJ, Deakyne CA, Jurisson SS. Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation. Nuclear Medicine and Biology. 43: 802-811. PMID 27694058 DOI: 10.1016/J.Nucmedbio.2016.08.017 |
0.353 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Wycoff DE, Morrow R, Phipps MD, Cutler CS, Ketring AR, Barnes CL, Jurisson SS. Dithiol Aryl Arsenic Compounds as Potential Diagnostic and Therapeutic Radiopharmaceuticals. Inorganic Chemistry. PMID 27453472 DOI: 10.1021/Acs.Inorgchem.6B01175 |
0.64 |
|
| 2016 |
Balkin ER, Gagnon K, Strong KT, Smith BE, Dorman EF, Emery RC, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Deuteron irradiation of W and WO3 for production of high specific activity (186)Re: Challenges associated with thick target preparation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 115: 197-207. PMID 27423020 DOI: 10.1016/J.Apradiso.2016.06.021 |
0.635 |
|
| 2016 |
Gott MD, Hayes CR, Wycoff DE, Balkin ER, Smith BE, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Wilbur DS, Jurisson SS. Accelerator-based production of the (99m)Tc-(186)Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2). Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 114: 159-166. PMID 27236832 DOI: 10.1016/J.Apradiso.2016.05.024 |
0.633 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Barnes CL, Ketring AR, Cutler CS, Jurisson SS. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals. Nuclear Medicine and Biology. 43: 288-95. PMID 27150031 DOI: 10.1016/J.Nucmedbio.2016.01.005 |
0.641 |
|
| 2016 |
Gott MD, DeGraffenreid AJ, Feng Y, Phipps MD, Wycoff DE, Embree MF, Cutler CS, Ketring AR, Jurisson SS. Chromatographic separation of germanium and arsenic for the production of high purity (77)As. Journal of Chromatography. A. PMID 26947162 DOI: 10.1016/J.Chroma.2016.02.074 |
0.608 |
|
| 2016 |
Li Y, Ma L, Gaddam V, Gallazzi F, Hennkens HM, Harmata M, Lewis MR, Deakyne CA, Jurisson SS. Synthesis, Characterization, and In Vitro Evaluation of New (99m)Tc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach. Inorganic Chemistry. PMID 26789775 DOI: 10.1021/Acs.Inorgchem.5B02306 |
0.375 |
|
| 2016 |
Jiang Z, Bandari RP, Stott Reynolds TJ, Xu J, Miao Y, Rold TL, Szczodroski AF, Jurisson SS, Smith CJ. Molecular imaging investigations of a 67Ga/64Cu labeled bivalent ligand, [RGD-Glu-(DO3A)-6-Ahx-RM2], targeting GRPR/αvβ3 biomarkers: A comparative study Radiochimica Acta. 104: 499-512. DOI: 10.1515/Ract-2015-2519 |
0.31 |
|
| 2016 |
DeGraffenreid AJ, Feng Y, Barnes CL, Ketring AR, Cutler CS, Jurisson SS. Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals Nuclear Medicine and Biology. 43: 288-295. DOI: 10.1016/j.nucmedbio.2016.01.005 |
0.568 |
|
| 2016 |
Makris G, Radford L, Gallazzi F, Jurisson S, Hennkens H, Papagiannopoulou D. Synthesis and evaluation of fac-[99mTc/Re(CO)3]+ complexes with a new (N,S,N) bifunctional chelating agent: The first example of a fac-[Re(CO)3(N,S,N-sst2-ANT)] complex bearing a somatostatin receptor antagonist peptide Journal of Organometallic Chemistry. 805: 100-107. DOI: 10.1016/J.Jorganchem.2016.01.005 |
0.372 |
|
| 2014 |
Wycoff DE, Gott MD, DeGraffenreid AJ, Morrow RP, Sisay N, Embree MF, Ballard B, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS. Chromatographic separation of selenium and arsenic: A potential (72)Se/(72)As generator. Journal of Chromatography. A. 1340: 109-14. PMID 24679827 DOI: 10.1016/J.Chroma.2014.03.033 |
0.615 |
|
| 2014 |
Gott MD, Ballard BD, Redman LN, Maassen JR, Taylor WA, Engle JW, Nortier FM, Birnbaum ER, John KD, Wilbur DS, Cutler CS, Ketring AR, Jurisson SS, Fassbender ME. Radiochemical study of re/w adsorption behavior on a strongly basic anion exchange resin Radiochimica Acta. 102: 325-332. DOI: 10.1515/Ract-2013-2144 |
0.587 |
|
| 2014 |
Makris G, Radford L, Gallazzi F, Jurisson S, Hennkens H, Papagiannopoulou D. New [99mTc(CO)3(NSN)]+ chelate conjugated to a somatostatin receptor-seeking peptide Nuclear Medicine and Biology. 41: 623. DOI: 10.1016/J.Nucmedbio.2014.05.074 |
0.315 |
|
| 2014 |
DeGraffenreid AJ, Cutler CS, Barnes C, Jurisson SS. Synthesis of tridentate ligand: Potential theranostic application of a radioarsenic trithiol complex Nuclear Medicine and Biology. 41: 629. DOI: 10.1016/J.Nucmedbio.2014.05.041 |
0.326 |
|
| 2014 |
Reinig K, Rotsch D, Radford L, Weis E, Taylor A, Barnes C, Jurisson S. Synthesis of novel rhenium and technetium N2O2 schiff base complexes Nuclear Medicine and Biology. 41: 624. DOI: 10.1016/J.Nucmedbio.2014.05.031 |
0.305 |
|
| 2014 |
Li Y, Kreuer JA, Demoin DW, Jurisson SS, Deakyne CA. Using potential energy surface scans to examine the bond dissociation energies of trans-ReOS2N2 and [ReOS3N]1- model complexes Computational and Theoretical Chemistry. 1048: 25-34. DOI: 10.1016/J.Comptc.2014.08.017 |
0.35 |
|
| 2013 |
Rotsch DA, Reinig KM, Weis EM, Taylor AB, Barnes CL, Jurisson SS. Novel rhenium(iii, iv, and v) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes Dalton Transactions. 42: 11614-11625. PMID 23824208 DOI: 10.1039/C3Dt51198G |
0.33 |
|
| 2013 |
Fassbender ME, Ballard B, Birnbaum ER, Engle JW, John KD, Maassen JR, Nortier FM, Lenz JW, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186gRe using WO3 targets Radiochimica Acta. 101: 339-346. DOI: 10.1524/Ract.2013.2031 |
0.642 |
|
| 2012 |
Carroll V, Demoin DW, Hoffman TJ, Jurisson SS. Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions. Radiochimica Acta. 100: 653-667. PMID 25382874 DOI: 10.1524/Ract.2012.1964 |
0.605 |
|
| 2012 |
Ballard B, Wycoff D, Birnbaum ER, John KD, Lenz JW, Jurisson SS, Cutler CS, Nortier FM, Taylor WA, Fassbender ME. Selenium-72 formation via nat Br(p,x) induced by 100 MeV protons: steps towards a novel 72Se/72As generator system. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 70: 595-601. PMID 22326368 DOI: 10.1016/J.Apradiso.2012.01.018 |
0.311 |
|
| 2012 |
Weis EM, Duval PB, Jurisson SS. Syntheses and structures of two uranyl complexes with DMPU Radiochimica Acta. 100: 237-241. DOI: 10.1524/Ract.2012.1911 |
0.339 |
|
| 2012 |
Jurisson SS, Wycoff DE, Degraffenreid A, Embree MF, Ketring AR, Cutler CS, Fassbender ME, Ballard B. Separation methods for high specific activity radioarsenic Aip Conference Proceedings. 1509: 215-217. DOI: 10.1063/1.4773971 |
0.561 |
|
| 2012 |
Bertch TC, Russ BE, Brown LC, Cutler CS, Ketring AR, Jurisson SS, Robertson JD. Selective gaseous extraction for low waste LEU-based economic isotope production Transactions of the American Nuclear Society. 107: 67. |
0.571 |
|
| 2011 |
Mohsin H, Jia F, Bryan JN, Sivaguru G, Cutler CS, Ketring AR, Miller WH, Simón J, Frank RK, Theodore LJ, Axworthy DB, Jurisson SS, Lewis MR. Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu. Bioconjugate Chemistry. 22: 2444-52. PMID 22053899 DOI: 10.1021/Bc200258X |
0.754 |
|
| 2011 |
Kannan R, Pillarsetty N, Gali H, Hoffman TJ, Barnes CL, Jurisson SS, Smith CJ, Volkert WA. Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re). Inorganic Chemistry. 50: 6210-9. PMID 21591746 DOI: 10.1021/Ic200491Z |
0.323 |
|
| 2011 |
Bigott-Hennkens HM, Dannoon SF, Noll SM, Ruthengael VC, Jurisson SS, Lewis MR. Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives. Nuclear Medicine and Biology. 38: 549-55. PMID 21531292 DOI: 10.1016/J.Nucmedbio.2010.10.006 |
0.747 |
|
| 2011 |
Lane SR, Sisay N, Carney B, Dannoon S, Williams S, Engelbrecht HP, Barnes CL, Jurisson SS. Re(v) and Re(iii) complexes with sal2phen and triphenylphosphine: Rearrangement, oxidation and reduction Dalton Transactions. 40: 269-276. PMID 21079821 DOI: 10.1039/C0Dt00993H |
0.771 |
|
| 2010 |
Akgun Z, Engelbrecht H, Fan KH, Barnes CL, Cutler CS, Jurisson SS, Lever SZ. The complexation of rhodium(III) with acyclic diaminedithioether (DADTE) ligands Dalton Transactions. 39: 10169-10178. PMID 20890539 DOI: 10.1039/C0Dt00813C |
0.367 |
|
| 2010 |
Lane SR, Nanda P, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Jurisson SS, Smith CJ. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model. Nuclear Medicine and Biology. 37: 751-61. PMID 20870150 DOI: 10.1016/J.Nucmedbio.2010.04.016 |
0.688 |
|
| 2010 |
Dannoon SF, Bigott-Hennkens HM, Ma L, Gallazzi F, Lewis MR, Jurisson SS. In vitro structure-activity relationship of Re-cyclized octreotide analogues. Nuclear Medicine and Biology. 37: 527-37. PMID 20610157 DOI: 10.1016/J.Nucmedbio.2010.03.008 |
0.761 |
|
| 2010 |
Bottenus BN, Kan P, Jenkins T, Ballard B, Rold TL, Barnes C, Cutler C, Hoffman TJ, Green MA, Jurisson SS. Gold(III) bis-thiosemicarbazonato complexes: synthesis, characterization, radiochemistry and X-ray crystal structure analysis. Nuclear Medicine and Biology. 37: 41-9. PMID 20122667 DOI: 10.1016/J.Nucmedbio.2009.08.003 |
0.387 |
|
| 2009 |
Liu Y, Terry J, Jurisson SS. Potential interferences on the pertechnetate-sulfide immobilization reaction Radiochimica Acta. 97: 33-41. DOI: 10.1524/Ract.2009.1569 |
0.318 |
|
| 2008 |
Bigott-Hennkens HM, Dannoon S, Lewis MR, Jurisson SS. In vitro receptor binding assays: general methods and considerations. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 52: 245-53. PMID 18475249 |
0.727 |
|
| 2008 |
Lane SR, Veerendra B, Rold TL, Sieckman GL, Hoffman TJ, Jurisson SS, Smith CJ. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor. Nuclear Medicine and Biology. 35: 263-72. PMID 18355681 DOI: 10.1016/J.Nucmedbio.2007.11.007 |
0.712 |
|
| 2008 |
Bigott-Hennkens HM, Junnotula S, Ma L, Gallazzi F, Lewis MR, Jurisson SS. Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series. Journal of Medicinal Chemistry. 51: 1223-30. PMID 18269231 DOI: 10.1021/Jm701056X |
0.328 |
|
| 2008 |
Arrigo LM, Galenas M, Bassil DB, Tucker SA, Kannan R, Katti KV, Barnes CL, Jurisson SS. Fluorescent phosphinimine as possible precursor to an anionic and fluorescent sensor for Tc-99 Radiochimica Acta. 96: 835-844. DOI: 10.1524/Ract.2008.1529 |
0.765 |
|
| 2008 |
Arrigo LM, Galenas M, Kannan R, Katti KV, Jurisson SS. Phosphinimines as selective extractants for Tc-99 pertechnetate Radiochimica Acta. 96: 175-181. DOI: 10.1524/Ract.2008.1497 |
0.759 |
|
| 2007 |
Mohsin H, Fitzsimmons J, Shelton T, Hoffman TJ, Cutler CS, Lewis MR, Athey PS, Gulyas G, Kiefer GE, Frank RK, Simon J, Lever SZ, Jurisson SS. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3. Nuclear Medicine and Biology. 34: 493-502. PMID 17591549 DOI: 10.1016/J.Nucmedbio.2007.03.006 |
0.734 |
|
| 2006 |
Mohsin H, Jia F, Sivaguru G, Hudson MJ, Shelton TD, Hoffman TJ, Cutler CS, Ketring AR, Athey PS, Simón J, Frank RK, Jurisson SS, Lewis MR. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu. Bioconjugate Chemistry. 17: 485-92. PMID 16536481 DOI: 10.1021/Bc0502356 |
0.77 |
|
| 2006 |
Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin. Nuclear Medicine and Biology. 33: 81-9. PMID 16459262 DOI: 10.1016/J.Nucmedbio.2005.09.006 |
0.407 |
|
| 2005 |
Benny PD, Green JL, Engelbrecht HP, Barnes CL, Jurisson SS. Reactivity of rhenium(V) oxo Schiff base complexes with phosphine ligands: rearrangement and reduction reactions. Inorganic Chemistry. 44: 2381-90. PMID 15792474 DOI: 10.1021/Ic048670J |
0.637 |
|
| 2005 |
Engelbrecht HP, Jurisson SS, Cutler CS, Den Drijver L, Roodt A. Solid state study on rhenium dimethylphosphinoethane complexes: X-ray crystal structures of trans-[ReO2 (dmpe)2]PF 6·2H2O, trans-[ReO(OH)(dmpe)2](CF 3SO3)2, trans-[ReN(Cl)(dmpe) 2]CF3SO3 and trans-[ReCl2(dmpe) 2]ReO4 Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry. 35: 83-99. DOI: 10.1081/Sim-200047553 |
0.325 |
|
| 2005 |
Green JL, Benny PD, Engelbrecht HP, Barnes CL, Jurisson SS. Substitution and intramolecular rearrangement of trans-[ReO(X)(acac 2en/pn)]0/+ (X = OH2 or Cl-) to yield asymmetric cis-[ReO(Y)(acac2en/pn)] complexes with cyanide and thiocyanate Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry. 35: 53-59. DOI: 10.1081/Sim-200047547 |
0.619 |
|
| 2004 |
Jurisson S, Gawenis J, Landa ER. Sorption of 99mTc radiopharmaceutical compounds by soils. Health Physics. 87: 423-8. PMID 15359190 DOI: 10.1097/01.Hp.0000128583.33124.7D |
0.739 |
|
| 2004 |
Lewis MR, Zhang J, Jia F, Owen NK, Cutler CS, Embree MF, Schultz J, Theodore LJ, Ketring AR, Jurisson SS, Axworthy DB. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice. Nuclear Medicine and Biology. 31: 213-23. PMID 15013487 DOI: 10.1016/J.Nucmedbio.2003.08.004 |
0.627 |
|
| 2004 |
Cheng Z, Chen J, Quinn TP, Jurisson SS. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cancer Research. 64: 1411-8. PMID 14973076 DOI: 10.1158/0008-5472.Can-03-0193 |
0.456 |
|
| 2003 |
Benny PD, Barnes CL, Piekarski PM, Lydon JD, Jurisson SS. Synthesis and characterization of novel rhenium(V) tetradentate N2O2 Schiff base monomer and dimer complexes. Inorganic Chemistry. 42: 6519-27. PMID 14514329 DOI: 10.1021/Ic030240Q |
0.626 |
|
| 2003 |
Li WP, Smith CJ, Cutler CS, Hoffman TJ, Ketring AR, Jurisson SS. Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm. Nuclear Medicine and Biology. 30: 241-51. PMID 12745015 DOI: 10.1016/S0969-8051(02)00418-3 |
0.645 |
|
| 2002 |
Gawenis JA, Holman KT, Atwood JL, Jurisson SS. Extraction of pertechnetate and perrhenate from water with deep-cavity [CpFe(arene)](+)-derivatized cyclotriveratrylenes. Inorganic Chemistry. 41: 6028-31. PMID 12425629 DOI: 10.1021/Ic0202312 |
0.76 |
|
| 2002 |
Cheng Z, Chen J, Miao Y, Owen NK, Quinn TP, Jurisson SS. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. Journal of Medicinal Chemistry. 45: 3048-56. PMID 12086490 DOI: 10.1021/Jm010408M |
0.512 |
|
| 2002 |
Hu F, Cutler CS, Hoffman T, Sieckman G, Volkert WA, Jurisson SS. Pm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2). Nuclear Medicine and Biology. 29: 423-30. PMID 12031877 DOI: 10.1016/S0969-8051(02)00290-1 |
0.365 |
|
| 2002 |
Chen J, Cheng Z, Miao Y, Jurisson SS, Quinn TP. Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting. Cancer. 94: 1196-201. PMID 11877745 DOI: 10.1002/Cncr.10284 |
0.477 |
|
| 2002 |
Jurisson SS, Benedict JJ, Elder RC, Deutsch E. Calcium affinity of coordinated diphosphonate ligands. Single-crystal structure of [(en)2Co(O2P(OH)CH2P(OH)O2)]ClO4.H2O. Implications for the chemistry of technetium-99m-diphosphonate skeletal imaging agents Cheminform. 14. DOI: 10.1021/Ic00151A013 |
0.537 |
|
| 2001 |
Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 1847-55. PMID 11752084 |
0.391 |
|
| 2001 |
Gawenis JA, Kauffman JF, Jurisson SS. Ion pairing as a strategy for extraction by modified supercritical carbon dioxide: extraction of radioactive metal ions. Analytical Chemistry. 73: 2022-6. PMID 11354485 DOI: 10.1021/Ac001195W |
0.746 |
|
| 2001 |
Li WP, Ma DS, Higginbotham C, Hoffman T, Ketring AR, Cutler CS, Jurisson SS. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nuclear Medicine and Biology. 28: 145-54. PMID 11295425 DOI: 10.1016/S0969-8051(00)00196-7 |
0.64 |
|
| 2001 |
Barnholtz SL, Lydon JD, Huang G, Venkatesh M, Barnes CL, Ketring AR, Jurisson SS. Syntheses and characterization of gold(III) tetradentate schiff base complexes. X-ray crystal structures of [Au(sal2pn)]Cl·2.5H2O and [Au(sal2en)]PF6 Inorganic Chemistry. 40: 972-976. DOI: 10.1021/Ic001073M |
0.646 |
|
| 2001 |
Chen J, Cheng Z, Miao Y, Jurisson SS, Quinn TP. Synthesis and characterization of DOTA-derivatized cyclic α-MSH peptide analogs Journal of Labelled Compounds and Radiopharmaceuticals. 44: S676-S678. DOI: 10.1002/Jlcr.25804401239 |
0.421 |
|
| 2000 |
Cutler CS, Smith CJ, Ehrhardt GJ, Tyler TT, Jurisson SS, Deutsch E. Current and potential therapeutic uses of lanthanide radioisotopes Cancer Biotherapy and Radiopharmaceuticals. 15: 531-545. PMID 11190486 DOI: 10.1089/Cbr.2000.15.531 |
0.536 |
|
| 2000 |
Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Research. 60: 5649-58. PMID 11059756 |
0.413 |
|
| 2000 |
Jia W, Ma D, Volkert EW, Ketring AR, Ehrhardt GJ, Jurisson SS. Production of No-Carrier-Added 105Rh from Neutron Irradiated Ruthenium Target Platinum Metals Review. 44: 50-55. |
0.573 |
|
| 1999 |
Goswami N, Higginbotham C, Volkert W, Alberto R, Nef W, Jurisson S. Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation. Nuclear Medicine and Biology. 26: 951-7. PMID 10708310 DOI: 10.1016/S0969-8051(99)00070-0 |
0.536 |
|
| 1999 |
Pillai MRA, Kothari K, Banerjee S, Samuel G, Suresh M, Sarma HD, Jurisson S. Radiochemical studies of 99mTc complexes of modified cysteine ligands and bifunctional chelating agents Nuclear Medicine and Biology. 26: 555-561. PMID 10473195 DOI: 10.1016/S0969-8051(99)00009-8 |
0.364 |
|
| 1999 |
Pillai MRA, Kothari K, Mathew B, Pilkwal NK, Jurisson S. Synthesis of heptadentate (N4O3) amine-phenol ligands and radiochemical studies with technetium-99m Nuclear Medicine and Biology. 26: 233-238. PMID 10100224 DOI: 10.1016/S0969-8051(98)00102-4 |
0.377 |
|
| 1999 |
Pillai MRA, Samuel G, Banerjee S, Mathew B, Sarma HD, Jurisson S. Technetium-99m complexes of polydentate amine-pyrrole and amine- thiophene ligands Nuclear Medicine and Biology. 26: 69-77. PMID 10096504 DOI: 10.1016/S0969-8051(98)00051-1 |
0.373 |
|
| 1999 |
Venkatesh M, Schlemper EO, Jurisson SS, Ketring AR, Volkert WA, Corlija M. Preparation of 105 Rh labeled monoclonal antibody (MAb B72.3) using aminobenzylpropyleneamineoxime as the bifunctional chelating agent; Comparison to 131 I labeled MAb B72.3 Radiochimica Acta. 85: 157-163. DOI: 10.1524/Ract.1999.85.34.157 |
0.603 |
|
| 1999 |
Pillai MRA, Kilcoin T, Kothari K, Ramamoorthy N, Lal R, Jurisson SS, Schlemper EO. Studies on 99mTc complexes of functionalised propylene amine-oxime (PnAO) ligands Journal of Labelled Compounds and Radiopharmaceuticals. 42: 1161-1173. DOI: 10.1002/(Sici)1099-1344(199912)42:12<1161::Aid-Jlcr271>3.0.Co;2-F |
0.367 |
|
| 1999 |
Hu F, Lydon JD, Jurisson S, Ketring A. Rhodium (III) complexes with acyclic tetrathioether ligands: Potential bifunctional chelates for use in radiotherapy Journal of Labelled Compounds and Radiopharmaceuticals. 42: S818-S820. |
0.608 |
|
| 1998 |
Giblin MF, Wang N, Hoffman TJ, Jurisson SS, Quinn TP. Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proceedings of the National Academy of Sciences of the United States of America. 95: 12814-8. PMID 9788997 DOI: 10.1073/Pnas.95.22.12814 |
0.325 |
|
| 1998 |
Jurisson S, Halihan MM, Lydon JD, Barnes CL, Nowotnik DP, Nunn AD. Linkage Isomerization of MSCN(CDOH)2(CDO)BMe to MNCS(CDOH)2(CDO)BMe (M = Tc, Re). Crystal Structures of TcNCS(CDOH)2(CDO)BMe, ReNCS(CDOH)2(CDO)BMe, and ReSCN(CDOH)2(CDO)BMe† Inorganic Chemistry. 37: 1922-1928. DOI: 10.1021/Ic971145I |
0.357 |
|
| 1997 |
Giblin MF, Jurisson SS, Quinn TP. Synthesis and characterization of rhenium-complexed α-melanotropin analogs Bioconjugate Chemistry. 8: 347-353. PMID 9177840 DOI: 10.1021/Bc9700291 |
0.334 |
|
| 1997 |
Jurisson SS, Ketring AR, Volkert WA. Rhodium-105 complexes as potential radiotherapeutic agents Transition Metal Chemistry. 22: 315-317. DOI: 10.1023/A:1018441230403 |
0.66 |
|
| 1997 |
Goodman DC, Reibenspies JH, Goswami N, Jurisson S, Darensbourg MY. A new macrocyclic N3S2 ligand and its nickel(II), cobalt(II), rhodium(III)-103, and rhodium(III)-105 complexes Journal of the American Chemical Society. 119: 4955-4963. DOI: 10.1021/Ja964187Z |
0.365 |
|
| 1997 |
Kannan S, Pillai MRA, Droege PA, Jurisson S, Barnes CL. Synthesis and crystal structure of a novel trinuclear copper(II) complex from amine-phenol ligand Inorganica Chimica Acta. 254: 397-400. DOI: 10.1016/S0020-1693(96)05177-8 |
0.312 |
|
| 1996 |
Venkatesh M, Goswami N, Volkert WA, Schlemper EO, Ketring AR, Barnes CL, Jurisson S. An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates. Nuclear Medicine and Biology. 23: 33-40. PMID 9004912 DOI: 10.1016/0969-8051(95)02012-8 |
0.656 |
|
| 1996 |
Goswami N, Alberto R, Barnes CL, Jurisson S. Rhodium(III) Complexes with Acyclic Tetrathioether Ligands. Effects of Backbone Chain Length on the Conformation of the Rh(III) Complex Inorganic Chemistry. 35: 7546-7555. DOI: 10.1021/Ic960952Z |
0.522 |
|
| 1996 |
Volkert WA, Jurisson S. Technetium-99m chelates as radiopharmaceuticals Topics in Current Chemistry. 176: 123-148. DOI: 10.1007/3-540-59469-8_5 |
0.307 |
|
| 1995 |
Pillai MRA, Kothari K, Jurisson S. Pentadentate chiral amine-phenol ligands: synthesis and radiochemical studies with 99mTc Applied Radiation and Isotopes. 46: 923-927. DOI: 10.1016/0969-8043(95)00180-L |
0.378 |
|
| 1988 |
JURISSON S, ASTON K, FAIR CK, SCHLEMPER EO, SHARP PR, TROUTNER DE. ChemInform Abstract: Effect of Ring Size on Properties of Technetium Amine Oxime Complexes. X-Ray Structures of TcO2Pent(AO)2, Which Contains an Unusual Eight-Membered Chelate Ring, and of TcOEn(AO)2. Cheminform. 19. DOI: 10.1002/chin.198807302 |
0.606 |
|
| 1987 |
Jurisson S, Aston K, Fair CK, Schlemper EO, Sharp PR, Troutner DE. Effect of ring size on properties of technetium amine oxime complexes. X-ray structures of TcO2Pent(AO)2, which contains an unusual eight-membered chelate ring, and of TcOEn(AO)2 Inorganic Chemistry. 26: 3576-3582. DOI: 10.1021/ic00268a031 |
0.605 |
|
| 1986 |
Jurisson S, Schlemper EO, Troutner DE, Canning LR, Nowotnik DP, Neirinckx RD. Synthesis, characterization, and X-ray structural determinations of technetium(V)-oxo-tetradentate amine oxime complexes Inorganic Chemistry. 25: 543-549. |
0.626 |
|
| 1984 |
Jurisson SS, Dancey K, McPartlin M, Tasker PA, Deutsch E. Synthesis, characterization, and electrochemical properties of technetium complexes containing both tetradentate schiff base and monodentate tertiary phosphine ligands: Single-crystal structure of trans-(N,N′-ethylenebis(acetylacetone iminato))bis(triphenylphosphine)technetium(III) hexafluorophosphate Inorganic Chemistry. 23: 4743-4749. DOI: 10.1021/Ic00194A063 |
0.564 |
|
| 1984 |
Jurisson S, Lindoy LF, Dancey KP, Mcpartlin M, Tasker PA, Uppal DK, Deutsch E. New oxotechnetium(V) complexes of N,N′-ethylenebis(acetylacetone imine), N,N′-ethylenebis(salicylideneamine), and o-phenylenebis(salicylideneamine). X-ray structures of the complexes of N,N′-ethylenebis(acetylacetone imine) and N,N′-ethylenebis(salicylideneamine) Inorganic Chemistry. 23: 227-231. DOI: 10.1021/Ic00170A021 |
0.544 |
|
| 1984 |
Bandoli G, Mazzi U, Wilcox BE, Jurisson S, Deutsch E. Synthesis and characterization of technetium(V) complexes with tridentate schiff base ligands. X-ray crystal structure of chloro[N-(2-hydroxyphenyl)salicylideneiminato]oxotechnetium(V) Inorganica Chimica Acta. 95: 217-223. DOI: 10.1016/S0020-1693(00)87470-8 |
0.527 |
|
| Show low-probability matches. |
